Report Detail
Global Precision Cancer Tests Market Size, Status and Forecast 2019-2025
- RnM2945202 |
- 14 February, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Other
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
In 2018, the global Precision Cancer Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Precision Cancer Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Cancer Tests development in United States, Europe and China.
The key players covered in this study
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Imaging
In Vitro Diagnostic
Others
Market segment by Application, split into
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Precision Cancer Tests status, future forecast, growth opportunity, key market and key players.
To present the Precision Cancer Tests development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Precision Cancer Tests are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Precision Cancer Tests Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Imaging
- 1.4.3 In Vitro Diagnostic
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Precision Cancer Tests Market Share by Application (2014-2025)
- 1.5.2 Cancer Research Centers
- 1.5.3 Cancer Hospital
- 1.5.4 Surgical Centers
- 1.5.5 Clinics
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Precision Cancer Tests Market Size
- 2.2 Precision Cancer Tests Growth Trends by Regions
- 2.2.1 Precision Cancer Tests Market Size by Regions (2014-2025)
- 2.2.2 Precision Cancer Tests Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Precision Cancer Tests Market Size by Manufacturers
- 3.1.1 Global Precision Cancer Tests Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Precision Cancer Tests Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
- 3.2 Precision Cancer Tests Key Players Head office and Area Served
- 3.3 Key Players Precision Cancer Tests Product/Solution/Service
- 3.4 Date of Enter into Precision Cancer Tests Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Precision Cancer Tests Market Size by Type (2014-2019)
- 4.2 Global Precision Cancer Tests Market Size by Application (2014-2019)
5 United States
- 5.1 United States Precision Cancer Tests Market Size (2014-2019)
- 5.2 Precision Cancer Tests Key Players in United States
- 5.3 United States Precision Cancer Tests Market Size by Type
- 5.4 United States Precision Cancer Tests Market Size by Application
6 Europe
- 6.1 Europe Precision Cancer Tests Market Size (2014-2019)
- 6.2 Precision Cancer Tests Key Players in Europe
- 6.3 Europe Precision Cancer Tests Market Size by Type
- 6.4 Europe Precision Cancer Tests Market Size by Application
7 China
- 7.1 China Precision Cancer Tests Market Size (2014-2019)
- 7.2 Precision Cancer Tests Key Players in China
- 7.3 China Precision Cancer Tests Market Size by Type
- 7.4 China Precision Cancer Tests Market Size by Application
8 Japan
- 8.1 Japan Precision Cancer Tests Market Size (2014-2019)
- 8.2 Precision Cancer Tests Key Players in Japan
- 8.3 Japan Precision Cancer Tests Market Size by Type
- 8.4 Japan Precision Cancer Tests Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Precision Cancer Tests Market Size (2014-2019)
- 9.2 Precision Cancer Tests Key Players in Southeast Asia
- 9.3 Southeast Asia Precision Cancer Tests Market Size by Type
- 9.4 Southeast Asia Precision Cancer Tests Market Size by Application
10 India
- 10.1 India Precision Cancer Tests Market Size (2014-2019)
- 10.2 Precision Cancer Tests Key Players in India
- 10.3 India Precision Cancer Tests Market Size by Type
- 10.4 India Precision Cancer Tests Market Size by Application
11 Central & South America
- 11.1 Central & South America Precision Cancer Tests Market Size (2014-2019)
- 11.2 Precision Cancer Tests Key Players in Central & South America
- 11.3 Central & South America Precision Cancer Tests Market Size by Type
- 11.4 Central & South America Precision Cancer Tests Market Size by Application
12 International Players Profiles
- 12.1 Abbott
- 12.1.1 Abbott Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Precision Cancer Tests Introduction
- 12.1.4 Abbott Revenue in Precision Cancer Tests Business (2014-2019)
- 12.1.5 Abbott Recent Development
- 12.2 BD
- 12.2.1 BD Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Precision Cancer Tests Introduction
- 12.2.4 BD Revenue in Precision Cancer Tests Business (2014-2019)
- 12.2.5 BD Recent Development
- 12.3 Bio-Rad
- 12.3.1 Bio-Rad Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Precision Cancer Tests Introduction
- 12.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2014-2019)
- 12.3.5 Bio-Rad Recent Development
- 12.4 Cynvenio Biosystems
- 12.4.1 Cynvenio Biosystems Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Precision Cancer Tests Introduction
- 12.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2014-2019)
- 12.4.5 Cynvenio Biosystems Recent Development
- 12.5 Foundation Medicine
- 12.5.1 Foundation Medicine Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Precision Cancer Tests Introduction
- 12.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2014-2019)
- 12.5.5 Foundation Medicine Recent Development
- 12.6 Genomic Health
- 12.6.1 Genomic Health Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Precision Cancer Tests Introduction
- 12.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2014-2019)
- 12.6.5 Genomic Health Recent Development
- 12.7 Illumina
- 12.7.1 Illumina Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Precision Cancer Tests Introduction
- 12.7.4 Illumina Revenue in Precision Cancer Tests Business (2014-2019)
- 12.7.5 Illumina Recent Development
- 12.8 Myriad Genetics
- 12.8.1 Myriad Genetics Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Precision Cancer Tests Introduction
- 12.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2014-2019)
- 12.8.5 Myriad Genetics Recent Development
- 12.9 NanoString Technologies
- 12.9.1 NanoString Technologies Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Precision Cancer Tests Introduction
- 12.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2014-2019)
- 12.9.5 NanoString Technologies Recent Development
- 12.10 QIAGEN
- 12.10.1 QIAGEN Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Precision Cancer Tests Introduction
- 12.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2014-2019)
- 12.10.5 QIAGEN Recent Development
- 12.11 Randox Laboratories
- 12.12 Roche
- 12.13 Philips
- 12.14 Thermo Fisher Scientific
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Precision Cancer Tests . Industry analysis & Market Report on Precision Cancer Tests is a syndicated market report, published as Global Precision Cancer Tests Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Precision Cancer Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
